Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 147, Issue 2, 2014, Pages 738-746

  Taylor, Matthew D ^a   Lapar, Damien J ^a   Isbell, James M ^a   Kozower, Benjamin D ^a   Lau, Christine L ^a   Jones, David R ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; LOBECTOMY; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY;

10; ACCP; ACSOG; AMERICAN COLLEGE OF CHEST PHYSICIANS; AMERICAN COLLEGE OF SURGEONS ONCOLOGY GROUP; COMPUTED TOMOGRAPHY; CT; DIFFUSING CAPACITY FOR CARBON MONOXIDE; DLCO; FEV1; FORCED EXPIRATORY VOLUME IN 1 SECOND; M-PFT; MARGINAL PULMONARY FUNCTION TEST; NON-SMALL CELL LUNG CARCINOMA; NSCLC; RADIATION THERAPY ONCOLOGY GROUP; RADIOFREQUENCY ABLATION; RFA; RTOG; SBRT; STEREOTACTIC BODY RADIOTHERAPY; STS; THE SOCIETY OF THORACIC SURGEONS;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PATIENT SELECTION; PNEUMONECTOMY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84892373462     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.09.064     Document Type: Article

References (15)

1. T. Crabtree, V. Puri, R. Timmerman, H. Fernando, J. Bradley, and P.A. Decker et al. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033) J Thorac Cardiovasc Surg 145 2013 692 699
2. R. Timmerman, R. Paulus, J. Galvin, J. Michalski, W. Straube, and J. Bradley et al. Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
3. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60 1995 615 622
4. M.D. Taylor, A.S. Nagji, C.M. Bhamidipati, N. Theodosakis, B.D. Kozower, and C.L. Lau et al. Tumor recurrence after complete resection for non-small cell lung cancer Ann Thorac Surg 93 2012 1813 1820
5. R. Santos, A. Colonias, D. Parda, M. Trombetta, R.H. Maley, and R. Macherey et al. Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer Surgery 134 2003 691 697
6. H.C. Fernando, R.S. Santos, J.R. Benfield, F.W. Grannis, R.J. Keenan, and J.D. Luketich et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer J Thorac Cardiovasc Surg 129 2005 261 267
7. C.G. Robinson, T.A. DeWees, I.M. EI Naqa, K.M. Creach, J.R. Olsen, and T.D. Crabtree et al. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer J Thorac Oncol 8 2013 192 201
8. A. Pennathur, J.D. Luketich, G. Abbas, M. Chen, H.C. Fernando, and W.E. Gooding et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients J Thorac Cardiovasc Surg 134 2007 857 864
9. M. Lanuti, A. Sharma, S.R. Digumarthy, C.D. Wright, D.M. Donahue, and J.C. Wain et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer J Thorac Cardiovasc Surg 137 2009 160 166
10. M.F. Berry, N.R. Villamizar-Ortiz, B.C. Tong, W.R. Burfeind Jr., D.H. Harpole, and T.A. D'Amico et al. Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy Ann Thorac Surg 89 2010 1044 1051
11. P. Magdeleinat, A. Seguin, M. Alifano, S. Boubia, and J.F. Regnard Early and long-term results of lung resection for non-small-cell lung cancer in patients with severe ventilatory impairment Eur J Cardiothorac Surg 27 2005 1099 1105
12. R.J. Cerfolio, M.S. Allen, V.F. Trastek, C. Deschamps, P.D. Scanlon, and P.C. Pairolero Lung resection in patients with compromised pulmonary function Ann Thorac Surg 62 1996 348 351
13. L. Puente-Maestú, F. Villar, G. González-Casurrán, N. Moreno, Y. Martínez, and C. Simón et al. Early and long-term validation of an algorithm assessing fitness for surgery in patients with postoperative FEV1 and diffusing capacity of the lung for carbon monoxide <40% Chest 139 2011 1430 1438
14. B.D. Kozower, S. Sheng, S.M. O'Brien, M.J. Liptay, C.L. Lau, and D.R. Jones et al. STS database risk models: predictors of mortality and major morbidity for lung cancer resection Ann Thorac Surg 90 2010 875 881
15. C.D. Wright, H.A. Gaissert, J.D. Grab, S.M. O'Brien, E.D. Peterson, and M.S. Allen Predictors of prolonged length of stay after lobectomy for lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk-adjustment model Ann Thorac Surg 85 2008 1857 1865